Decision Support for Vaccine Hesitancy
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new tool called LetsTalkShots, designed to help parents make informed decisions about vaccinating their children. The researchers aim to determine if this tool can increase vaccine uptake by providing information directly to parents and integrating it into the healthcare provider's workflow. Participants will be divided into groups, with some receiving regular vaccine reminders and others accessing the LetsTalkShots platform. Parents of children who have a vaccine due soon and have an appointment at the Children's Healthcare of Atlanta Hughes Spalding Primary Care Clinic are eligible to join. As an unphased trial, this study offers a unique opportunity for parents to contribute to innovative healthcare solutions that could improve vaccine uptake.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this platform is safe for improving vaccine uptake?
Research has shown that LetsTalkShots helps people make decisions about vaccines. User feedback indicates that the information is clear and reliable. Most people found it both interesting and helpful. While LetsTalkShots aims to improve understanding of vaccines, it involves no medication or physical treatment. Consequently, there are no reports of side effects or safety issues for users. It serves solely as a tool to help people make informed vaccine choices.12345
Why are researchers excited about this trial?
Researchers are excited about this trial because it's exploring new ways to address vaccine hesitancy using digital tools. Unlike traditional approaches that may involve direct conversations with healthcare providers, this trial tests a digital decision support system called LetsTalkShots (LTS). This system integrates into existing workflows, providing tailored reminders and information to parents based on their child’s birthdate and MYchart account status. By leveraging technology to deliver targeted, personalized information, researchers hope to improve vaccination rates and better understand how digital interventions can influence health decisions.
What evidence suggests that this trial's treatments could be effective for improving vaccine uptake?
Research shows that LetsTalkShots, evaluated in this trial, helps people make informed vaccine choices. One study found that 85.5% of users considered the information interesting, and 87% found it helpful. The system provides personalized content to address specific vaccine concerns. This customized approach has been well-received, even by those initially unsure. Engaging animations and clear communication enhance its effectiveness by building trust and understanding about vaccine risks and benefits. Overall, LetsTalkShots aims to improve vaccine uptake by making information easy to access and relate to.12346
Who Is on the Research Team?
Daniel Salmon, PhD
Principal Investigator
Johns Hopkins Bloomberg School of Public Health
Are You a Good Fit for This Trial?
This trial is for individuals who are hesitant or refuse vaccines. It aims to improve vaccine acceptance by using a platform that reminds patients of appointments and provides decision support tools for both patients and providers.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Providers participate in CME sessions and parents receive tailored vaccine messaging through the LTS platform
Follow-up
Participants are monitored for vaccine uptake and provider adoption of the integrated platform
What Are the Treatments Tested in This Trial?
Interventions
- LetsTalkShots
Trial Overview
The study tests an integrated platform with two main features: 'LetsTalkShots', which offers decision support to patients and healthcare providers, and an appointment reminder system, all within the electronic health record (EHR) system.
How Is the Trial Designed?
4
Treatment groups
Experimental Treatment
Placebo Group
Among patients without a MYchart account, those with odd birthdates will receive a link to the LTS website (patient-facing CDS) but no integration into the provider workflow.
Parents of patients with odd birthdates (e.g. April 13) and vaccines due at the index appointment who also have a MYchart account will receive a text message directing the parent to the LTS server with integration into the provider workflow
Patients with an even birthdate (e.g. April 14) who have a MYchart account will receive a regular text message and e-mail appointment reminder with a vaccine primer (e.g. "Vaccines are due and reserved for the participant's child"), but no patient- or provider-facing CDS.
As in the other control group, those without a MYchart account and an even birthdate (e.g. April 14) will receive a text message and e-mail appointment reminder with a vaccine primer but no patient- or provider-facing CDS.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins Bloomberg School of Public Health
Lead Sponsor
Emory University
Collaborator
Children's Healthcare of Atlanta
Collaborator
Merck & Company
Collaborator
Published Research Related to This Trial
Citations
LetsTalkShots: personalized vaccine risk communication
Our group has focused on addressing vaccine hesitancy and supporting vaccination decision-making, often resulting in increased vaccine ...
2.
researchgate.net
researchgate.net/publication/372038539_LetsTalkShots_personalized_vaccine_risk_communicationLetsTalkShots: personalized vaccine risk communication
Most respondents indicated that the information presented was interesting (85.5%), clear (96.0%), helpful (87.0%), and trustworthy (82.2%).
Let's Talk Shots
LetsTalkShots is designed to support vaccine decision-making. It shares engaging animated content based on a person's questions or concerns.
4.
files.comminit.com
files.comminit.com/content/letstalkshots-personalized-vaccine-risk-communicationLetsTalkShots: Personalized Vaccine Risk Communication
The animations were well received even among subpopulations with lower reported usability. For example, 46% of persons who were not confident in ...
LetsTalkShots: personalized vaccine risk communication
Tailored vaccine risk communication can assist decision makers as they consider vaccination for themselves, their families, ...
6.
health.comminit.com
health.comminit.com/content/letstalkshots-personalized-vaccine-risk-communicationLetsTalkShots: Personalized Vaccine Risk Communication
"While not a panacea for the global challenge of vaccine hesitancy, tailored vaccine risk communication can assist decision makers as they ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.